Search

Subject Sativex -- cannabinoid stimulation

1. Q23 A double blind, cross over, placebo-controlled, phase II trial of Sativex in Huntington's Disease. (29th August 2012)

Authors:
Caldentey, JG; Lopéz-Sendón, JL; Trigo, P; Ruiz, C; Ribas, GG; Aguilar, M; Galvez, MA; Pablo, I; Galve-Roth, I; Sagredo, O; Fernandez-Ruiz, JJ; Guzman, M; García, J
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 83(2012)Supplement 1
Page Start:
A62
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search